ArticleFrontiers in microbiology2026
Recombinant RBD-based subunit vaccines incorporating high-frequency mutation sites elicit cross-immunity and robust protection against SARS-CoV-2.
Zhiguang Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.